Alzheimer’s disease drug development pipeline: 2024

Cummings, Jeffrey, Zhou, Yadi, Lee, Garam, Zhong, Kate, Fonseca, Jorge, Cheng, Feixiong·2024·Alzheimer's & Dementia: Translational Research & Clinical Interventions

DOI 10.1002/trc2.12465

Cited by (334)

Items 301–334 of 334

Blood‐based proteomic signature of amyloidosis: identification of novel regulators of amyloid load
Yike Chen, Michael R. Duggan, Jigyasha Timsina, Ying Xu, Daniel Western, Katherine Gong, Menghan Liu, John Budde, Suzanne E. Schindler, John C. Morris et al. · 2026 · Alzheimer s & Dementia
Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non‐pharmacological strategies
Humberto Martínez-Orozco, Jesús Andrade-Guerrero, Nelly Jovana Pasten-Castrejón, Chryslaine Rodríguez‐Tanty, Sofía Y. Díaz-Cintra · 2026 · Alzheimer s & Dementia
In-vitro modelling of Alzheimer’s disease using cholinergic neurons derived from human neuroblastoma (SH-SY5Y) retinoic acid-induced differentiation
Muhammad-Safuan Zainuddin, Kasthuri Bai Magalingam, Narendra Pamidi, Adzzie Shazleen Azman, Saatheeyavaane Bhuvanendran · 2026 · Molecular Biology Reports
Deep contrastive learning framework identifies cell‐type‐specific drug targets in Alzheimer's disease
Yuxin Yang, Jie-Lin Xu, Yuan Hou, Ya-Di Zhou, A. Saykin, Fei-Xiong Cheng · 2026 · Alzheimer's & Dementia
Neuroinflammation in neurodegenerative diseases: pathogenic pathways and emerging pharmacotherapeutic targets in Alzheimer’s and Parkinson’s disease
Ravi Ranjan Kumar, Kamaljeet, Sourabh Kosey · 2026 · Inflammopharmacology
Mapping Digital and Assistive Technologies for Dementia and Related Neurodegenerative Conditions: A Scoping Review
Selin Birgen, Macy Fan, Sikander Chimbaiwala, Julian Jeyasingh‐Jacob, Christopher Fox, Helen Dawes, Shlomi Haar · 2026 · medRxiv
BDNF–amyloid-β Axis in Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
Fangfang Liu, Y Huang, Aiping Wang, LIU Peiyan, Haolin Wu, Haofei Fan · 2026 · Frontiers in Molecular Neuroscience
Attitudes of specialist memory-clinic patients with early symptomatic Alzheimer’s disease towards lecanemab: results from a multicenter survey in Europe
Jonathan Vöglein, Johannes Levin, Elisabeth Stögmann · 2026 · Scientific Reports
Generative large language models in the clinical management of Alzheimer’s disease and mild cognitive impairment
Yosef Adiniaev, Mahmud Omar, Oved Daniel, Tohar M Timor, Yiftach Barash, Olga Rachel Brook, Eyal Klang, Alon Gorenshtein · 2026 · Neurological Sciences
Nurses' Attitudes Toward Innovative Neurotherapies in Memory Disorders: A Pilot Study
Sini Huoponen, Juho Kettunen, Signe Mežinska · 2026 · CNS Neuroscience & Therapeutics
Representational efficiency and noise robustness in hybrid quantum-classical graph neural networks
Istiyak Amin Santo, Hasanul Bannah, Md Serajun Nabi, Hezerul Bin Abdul Karim · 2026 · Discover Quantum Science
Amyloid‐β Immunotherapy
P. K. Sahu, S. K. Prusty, M. Khandai · 2026
Immunotherapy in Alzheimer's Disease
Mangal Jyoti Das, Pratap Kumar Sahu · 2026
CellSwarm-AD: A Multi-Scale Agent-Based Framework for Virtual Alzheimer’s Disease Trials
Chun-Lin Tan, Xiang-mei Zheng, Yunfei Zhu, Quan-Quan Xiong, Han Li, Xuanlin Meng · 2026 · International Journal of Molecular Sciences
Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue
Wushan T. Jayalath, Medha Jaimini Gunaratna, Chamila Chathuranga Kadigamuwa, Charitha Jayaruk Thambiliyagodage, Jayangika N. Dahanayake · 2026 · Applied Biosciences
Apraxia and the Progressive Loss of Functional Integration in Alzheimer’s Disease: A Neurocognitive Framework
Marco Sanna · 2026 · Swiss Archives of Neurology Psychiatry and Psychotherapy
Pathological depositions in human disease: converging mechanisms in atherosclerosis, Alzheimer's disease, and related disorders
Louis Ragolia · 2026 · Molecular Biomedicine
Bacopa monnieri and Alzheimer’s disease: mechanistic convergence, cognitive outcomes and translational perspectives
Ankita Kumawat, Madan Mohan Sharma, Sumit Nathani · 2026 · Inflammopharmacology
Neuroinflammatory and molecular pathways in Alzheimer’s disease: mechanistic crosstalk and emerging therapeutic opportunities
Abhay Thakur, Rohit R. Sharma, Sneha Kumari, Dev Prakash, A Sanjana Devi · 2026 · Inflammopharmacology
Anatomy of a Setback: A Taxonomy of Clinical Trial Failures in Alzheimer's Disease and Strategic Lessons for the Future
Enzo Emanuele, Piercarlo Minoretti · 2026 · The FASEB Journal
Xanthones and Their Nitrogen and Sulfur Analogs in Alzheimer’s Disease: Recent Progress Toward Multifunctional Therapeutics
Daniela Malafaia, Lúcia Melo, Artur M. S. Silva, Hélio M. T. Albuquerque · 2026 · ChemMedChem
Chronotherapy: maximizing drug efficacy, reducing side effects, and improving patient outcomes through circadian alignment
Mansour Awadh Alanazi · 2026 · The Annals of Clinical and Analytical Medicine
Targeting cytokine-driven neuroinflammation in Alzheimer’s disease: mechanistic insights and pharmacological strategies
Rufaida Wasim · 2026 · Inflammopharmacology
Comparative efficacy of neuromodulation techniques for Alzheimer’s disease: a systematic review and network meta-analysis of randomized controlled trials
Yuan Liu, Shiyu Liu, Huayu Yan, Xin Yang, Yabo Wu, Chang Liu, Yumin Xu · 2026 · Frontiers in Neuroscience
Endocannabinoid System Genes in Dementia: A Systematic Mendelian Randomization Study of Functional Variants and Tissue-Specific Expression Across Clinical, Molecular, and Neuroimaging Phenotypes
Sara Javidnia, Ville Karhunen, Benjamin A. R. Woolf, Stephen Burgess, Petroula Proitsi, Latha Velayudhan, Sagnik Bhattacharyya · 2026 · medRxiv
Alzheimer's disease heterogeneity and co‐pathologies: Defining novel targets, biomarkers, modalities, and research methodologies
Malú G. Tansey, Sasha Bozeat, Peter Ackerman, Alireza Atri, Christopher J. Barnum, Patrik Brundin, Carlos M Abreu de Carvalho, Adam Fleisher, Ana Graf, Elizabeth Head et al. · 2026 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Epigenetic memory and allostatic integrity: a theoretical integration of the hierarchical-circular model using a longitudinal methylation signature of dementia
Samuel Ruesga Mundo · 2026 · Frontiers in Aging Neuroscience
Disproportionality analysis of adverse event signals associated with seven Alzheimer’s drugs: insights from the FAERS database
Kai Liu, Xiaohu Yang, Lingti Kong · 2026 · Frontiers in Pharmacology
Application of unsupervised and supervised machine learning approaches to blood-based biomarkers of Alzheimer’s disease in a memory clinic cohort
Edoardo Guido Torrigiani, Davide Cianca, Lorenzo Gaetani · 2026 · Frontiers in Aging Neuroscience
Non-invasive neuromodulation in Alzheimer’s disease: toward brain–heart coupling as a candidate framework for biomarker-guided adaptive intervention
Weiran Zheng, Yuyu Ma, Chi Su, Zhiying Qiu, Ziyi Yan, Guizhi Xu, Duyan Geng, Alan Wang · 2026 · Reviews in the Neurosciences
New treatments on the horizon for Alzheimer’s and other neurodegenerative diseases
Hannah Bailey, Robert Layfield, Eva Žerovnik · 2026 · Elsevier eBooks
Synthetic Protein Mimetic Modulators of Tau Aggregation
Diannelle Lacambra · 2026
GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon
Mohamed Alsharif, Omran Shrebaty, Mohammad Ammar Aloudah, Mayar Alqahtani, Raghad Saud AlOubili, Marafi Jammaa Ahmed, Bana AlBani, Ahmad El Bana · 2026 · Frontiers in Aging Neuroscience
Reverse the progression of Alzheimer’s disease through Nano-ERASER-based adult neuroregeneration
Wang, Mingming, VanderVeen, Brandon, Xu, Zhixuan Annie, Xu, Ying, Mintzer, Jacobo, Murphy, Angela, Zhang, Quanguang, Xu, Peisheng · 2026 · Cell Biomaterials